Hand-out
Press Releases
December 10, 2024
Qnovia, Inc. Raises $16 Million in Series B Financing to Advance Lead Asset RespiRx™ Nicotine Inhaler as a Prescription Smoking Cessation Therapy
- Company has raised $50 million since its inception -


